These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression. Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263 [TBL] [Abstract][Full Text] [Related]
26. Dual-energy CT for characterization of the incidental adrenal mass: preliminary observations. Gnannt R; Fischer M; Goetti R; Karlo C; Leschka S; Alkadhi H AJR Am J Roentgenol; 2012 Jan; 198(1):138-44. PubMed ID: 22194489 [TBL] [Abstract][Full Text] [Related]
27. Advanced Hepatocellular Carcinoma: early evaluation of response to targeted therapy and prognostic value of Perfusion CT and Dynamic Contrast Enhanced-Ultrasound. Preliminary results. Frampas E; Lassau N; Zappa M; Vullierme MP; Koscielny S; Vilgrain V Eur J Radiol; 2013 May; 82(5):e205-11. PubMed ID: 23273822 [TBL] [Abstract][Full Text] [Related]
28. Role of perfusion CT in differentiating between various cerebral masses using normalized permeability surface area product and cerebral blood volume. Lee YJ; Ahn KJ; Kim BS; Yoo WJ Clin Imaging; 2012; 36(6):680-7. PubMed ID: 23153995 [TBL] [Abstract][Full Text] [Related]